연구동향 분석
박사

Role of the tetraspanin CD9 in cellular senescence and atherosclerosis = 세포노화와 동맥경화에서 tetraspanin CD9의 역할

조정희 2015년

논문상세정보
인용/피인용
' Role of the tetraspanin CD9 in cellular senescence and atherosclerosis = 세포노화와 동맥경화에서 tetraspanin CD9의 역할' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • atherosclerosis
  • cd9
  • senescence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
137 0

0.0%

' Role of the tetraspanin CD9 in cellular senescence and atherosclerosis = 세포노화와 동맥경화에서 tetraspanin CD9의 역할' 의 참고문헌

  • Zheng R, Yano S, Zhang H, Nakataki E, Tachibana I, Kawase I, Hayashi S, Sone S: CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice. Oncol Res 15(7-8): 365-372, 2005.
  • Zhang XA, Bontrager AL, Hemler ME: Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 276(27): 25005-25013, 2001.
  • Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258(5081): 468-471, 1992.
  • Yu M, Kim YJ, Kang DH: Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6(1): 30-39, 2011.
  • Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-Madrid F: Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19(9): 434-446, 2009.
  • Wymann MP, Marone R: Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr Opin Cell Biol 17(2): 141-149, 2005.
  • Weksler ME, Pawelec G, Franceschi C: Immune therapy for age-related diseases. Trends Immunol 30(7): 344-350, 2009.
  • Wang JC, Bennett M: Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111(2): 245-259, 2012.
  • Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P: Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 36(8): 1327-1347, 2001.
  • Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J Biol Chem 269(7): 5241-5248, 1994.
  • Vargas J, Feltes BC, Poloni Jde F, Lenz G, Bonatto D: Senescence; an endogenous anticancer mechanism. Front Biosci (Landmark Ed) 17: 2616-2643, 2012.
  • Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK: Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105(12): 1429-1435, 2002.
  • Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M: Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79(5): 509-516, 1998.
  • Shelton DN, Chang E, Whittier PS, Choi D, Funk WD: Microarray analysis of replicative senescence. Curr Biol 9(17): 939-945, 1999.
  • Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26(5): 867-874, 2005.
  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5): 593-602, 1997.
  • Serrano M, Blasco MA: Putting the stress on senescence. Curr Opin Cell Biol 13(6): 748-753, 2001.
  • Seigneuret M, Delaguillaumie A, Lagaudriere-Gesbert C, Conjeaud H: Structure of the tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion. J Biol Chem 276(43): 40055-40064, 2001.
  • Sato H, Sato M, Kanai H, Uchiyama T, Iso T, Ohyama Y, Sakamoto H, Tamura J, Nagai R, Kurabayashi M: Mitochondrial reactive oxygen species and c- Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc Res 67(4): 714-722, 2005.
  • Samuels Y, Diaz LA, Jr., Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE: Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7(6): 561-573, 2005.
  • Sabatini DM: mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6(9): 729-734, 2006.
  • Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C: CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26(11): 2657-2665, 1996.
  • Royall JA, Ischiropoulos H: Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302(2): 348-355, 1993.
  • Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med 340(2): 115-126, 1999.
  • Ray R, Shah AM: NADPH oxidase and endothelial cell function. Clin Sci (Lond) 109(3): 217-226, 2005.
  • Radad K, Rausch WD, Gille G: Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 49(4): 379-386, 2006.
  • Poyatos JF, Carnero A: Non-neutral role of replicative senescence in tissue homeostasis and tumorigenesis. J Theor Biol 230(3): 333-341, 2004.
  • Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71(2): 343-353, 1992.
  • Pirillo A, Norata GD, Catapano AL: LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013: 152786, 2013.
  • Ono M, Handa K, Withers DA, Hakomori S: Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res 59(10): 2335-2339, 1999.
  • Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S: Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 57(5): 577-585, 2011.
  • Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW: Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113(6): 703-716, 2003.
  • Nardella C, Clohessy JG, Alimonti A, Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev Cancer 11(7): 503-511, 2011.
  • Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14(1): 133-140, 1994.
  • Nakamoto T, Murayama Y, Oritani K, Boucheix C, Rubinstein E, Nishida M, Katsube F, Watabe K, Kiso S, Tsutsui S, Tamura S, Shinomura Y, Hayashi N: A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol 44(9): 889-896, 2009.
  • Naka K, Tachibana A, Ikeda K, Motoyama N: Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 279(3): 2030-2037, 2004.
  • Muller M: Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11(1): 59-98, 2009.
  • Mori M, Mimori K, Shiraishi T, Haraguchi M, Ueo H, Barnard GF, Akiyoshi T: Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res 4(6): 1507-1510, 1998.
  • Miyake M, Koyama M, Seno M, Ikeyama S: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174(6): 1347-1354, 1991.
  • Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A, Okabe M, Mekada E: Requirement of CD9 on the egg plasma membrane for fertilization. Science 287(5451): 321- 324, 2000.
  • Miao WM, Vasile E, Lane WS, Lawler J: CD36 associates with CD9 and integrins on human blood platelets. Blood 97(6): 1689-1696, 2001.
  • Masai N, Tatebe J, Yoshino G, Morita T: Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-kappaB pathway. Circ J 74(10): 2216-2224, 2010.
  • Manning BD, Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129(7): 1261-1274, 2007.
  • Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F: Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 29(9): 1370- 1375, 2009.
  • Lowe SW, Cepero E, Evan G: Intrinsic tumour suppression. Nature 432(7015): 307-315, 2004.
  • Longo N, Yanez-Mo M, Mittelbrunn M, de la Rosa G, Munoz ML, Sanchez- Madrid F, Sanchez-Mateos P: Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 98(13): 3717-3726, 2001.
  • Liang J, Slingerland JM: Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2(4): 339-345, 2003.
  • Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP: Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278(10): 8516-8525, 2003.
  • Le Naour F, Charrin S, Labas V, Le Caer JP, Boucheix C, Rubinstein E: Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells. Cancer Immunol Immunother 53(3): 148-152, 2004.
  • Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA: Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell 4(1): 12, 2012.
  • Kotha J, Zhang C, Longhurst CM, Lu Y, Jacobs J, Cheng Y, Jennings LK: Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasia. Atherosclerosis 203(2): 377-386, 2009.
  • Kotha J, Longhurst C, Appling W, Jennings LK: Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway. Exp Cell Res 314(8): 1811-1822, 2008.
  • Ko EM, Lee IY, Cheon IS, Kim J, Choi JS, Hwang JY, Cho JS, Lee DH, Kang D, Kim SH, Choe J: Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation. Mol Cells 22(1): 70-77, 2006.
  • Kim TW, Kim HJ, Lee C, Kim HY, Baek SH, Kim JH, Kwon KS, Kim JR: Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system. Exp Gerontol 43(4): 286-295, 2008.
  • Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR: Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18(11): 4543-4552, 2007.
  • Kim JR, Lee SR, Chung HJ, Kim S, Baek SH, Kim JH, Kim YS: Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity. Exp Mol Med 35(5): 403-411, 2003.
  • Kazerounian S, Duquette M, Reyes MA, Lawler JT, Song K, Perruzzi C, Primo L, Khosravi-Far R, Bussolino F, Rabinovitz I, Lawler J: Priming of the vascular endothelial growth factor signaling pathway by thrombospondin- 1, CD36, and spleen tyrosine kinase. Blood 117(17): 4658-4666, 2011.
  • Kamisasanuki T, Tokushige S, Terasaki H, Khai NC, Wang Y, Sakamoto T, Kosai K: Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochem Biophys Res Commun 413(1): 128-135, 2011.
  • Kamata H, Hirata H: Redox regulation of cellular signalling. Cell Signal 11(1): 1- 14, 1999.
  • Jones PH, Bishop LA, Watt FM: Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4(4-5): 297-305, 1996.
  • Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost- Alimova M, Protopopov A, Cadinanos J, Horner JW, Maratos-Flier E, Depinho RA: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469(7328): 102-106, 2011.
  • Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K, Taniguchi N: Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171(3): 291-298, 1997.
  • Imanishi T, Hano T, Sawamura T, Nishio I: Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31(7): 407-413, 2004.
  • Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M: Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177(5): 1231-1237, 1993.
  • Huang W, Febbraio M, Silverstein RL: CD9 tetraspanin interacts with CD36 on the surface of macrophages: a possible regulatory influence on uptake of oxidized low density lipoprotein. PLoS One 6(12): e29092, 2011.
  • Huang CI, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M: Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153(3): 973-983, 1998.
  • Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ: Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86(1): 69-78, 2002.
  • Hong IK, Kim YM, Jeoung DI, Kim KC, Lee H: Tetraspanin CD9 induces MMP- 2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med 37(3): 230-239, 2005.
  • Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW: DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287(5459): 1824-1827, 2000.
  • Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, Kodama K, Doi O, Miyake M: Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55(24): 6040-6044, 1995.
  • Hemler ME: Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397-422, 2003.
  • Hemler ME: Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6(10): 801-811, 2005.
  • Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp. Cell. Res., 25: 585-621, 1961
  • Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345(6274): 458-460, 1990.
  • Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R: A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87(1): 26-32, 2000.
  • Gorgoulis VG, Halazonetis TD: Oncogene-induced senescence: the bright and dark side of the response. Curr Opin Cell Biol 22(6): 816-827, 2010.
  • Garfinkel S, Brown S, Wessendorf JH, Maciag T: Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 91(4): 1559- 1563, 1994.
  • Galle J, Hansen-Hagge T, Wanner C, Seibold S: Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185(2): 219-226, 2006.
  • Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 408(6809): 239-247, 2000.
  • Ferbeyre G, de Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ, Lowe SW: Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 22(10): 3497-3508, 2002.
  • Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, Carrier M, Thorin E: Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol 86(11): 761-769, 2008.
  • Diplock AT, Rice-Evans CA, Burdon RH: Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res 54(7 Suppl): 1952s-1956s, 1994.
  • Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al.: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92(20): 9363-9367, 1995.
  • Deng W, Tsao SW, Guan XY, Lucas JN, Cheung AL: Role of short telomeres in inducing preferential chromosomal aberrations in human ovarian surface epithelial cells: A combined telomere quantitative fluorescence in situ hybridization and whole-chromosome painting study. Genes Chromosomes Cancer 37(1): 92-97, 2003.
  • Cristofalo VJ, Volker C, Francis MK, Tresini M: Age-dependent modifications of gene expression in human fibroblasts. Crit Rev Eukaryot Gene Expr 8(1): 43-80, 1998.
  • Chen Z, Carracedo A, Lin HK, Koutcher JA, Behrendt N, Egia A, Alimonti A, Carver BS, Gerald W, Teruya-Feldstein J, Loda M, Pandolfi PP: Differential p53-independent outcomes of p19(Arf) loss in oncogenesis. Sci Signal 2(84): ra44, 2009.
  • Chai D, Wang B, Shen L, Pu J, Zhang XK, He B: RXR agonists inhibit highglucose- induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic Biol Med 44(7): 1334-1347, 2008.
  • Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R, Salazar EP: Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol 89(11): 843-852, 2010.
  • Carnevale R, Pignatelli P, Lenti L, Buchetti B, Sanguigni V, Di Santo S, Violi F: LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 21(3): 927-934, 2007.
  • Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 5573: 1655-1657,2002.
  • Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9): 729-740, 2007.
  • Campisi J, Kim SH, Lim CS, Rubio M: Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 36(10): 1619-1637, 2001.
  • Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA: Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64(21): 7678-7681, 2004.
  • Cajot JF, Sordat I, Silvestre T, Sordat B: Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57(13): 2593-2597, 1997.
  • Cailleteau L, Estrach S, Thyss R, Boyer L, Doye A, Domange B, Johnsson N, Rubinstein E, Boucheix C, Ebrahimian T, Silvestre JS, Lemichez E, Meneguzzi G, Mettouchi A: alpha2beta1 integrin controls association of Rac with the membrane and triggers quiescence of endothelial cells. J Cell Sci 123(Pt 14): 2491-2501, 2010.
  • Boucheix C, Rubinstein E: Tetraspanins. Cell Mol Life Sci 58(9): 1189-1205, 2001.
  • Boucheix C, Benoit P: CD9 antigen: will platelet physiology help to explain the function of a surface molecule during hemopoietic differentiation? Nouv Rev Fr Hematol 30(4): 201-202, 1988.
  • Boisen L, Drasbek KR, Pedersen AS, Kristensen P: Evaluation of endothelial cell culture as a model system of vascular ageing. Exp Gerontol 45(10): 779- 787, 2010.
  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349): 349-352, 1998.
  • Blando J, Portis M, Benavides F, Alexander A, Mills G, Dave B, Conti CJ, Kim J, Walker CL: PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol 174(5): 1869-1879, 2009.
  • Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA: Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 4(8): 691-704, 2012.
  • Berditchevski F: Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 114(Pt 23): 4143-4151, 2001.
  • Berditchevski F, Zutter MM, Hemler ME: Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 7(2): 193-207, 1996.
  • Berditchevski F, Odintsova E: Tetraspanins as regulators of protein trafficking. Traffic 8(2): 89-96, 2007.
  • Berditchevski F, Odintsova E: Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 146(2): 477-492, 1999.
  • Ben-Porath I, Weinberg RA: When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113(1): 8-13, 2004.
  • Ben-Porath I, Weinberg RA: The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37(5): 961-976, 2005.
  • Baudoux B, Castanares-Zapatero D, Leclercq-Smekens M, Berna N, Poumay Y: The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 79(1): 41-51, 2000.
  • Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281(5383): 1674-1677, 1998.
  • Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM: Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479(7372): 232-236, 2011.
  • Astle MV, Hannan KM, Ng PY, Lee RS, George AJ, Hsu AK, Haupt Y, Hannan RD, Pearson RB: AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31(15): 1949-1962, 2012.
  • Astle MV, Hannan KM, Ng PY, Lee RS, George AJ, Hsu AK, Haupt Y, Hannan RD, Pearson RB: AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31(15): 1949-1962, 2011.
  • Akhtar N, Dickerson EB, Auerbach R: The sponge/Matrigel angiogenesis assay. Angiogenesis 5(1-2): 75-80, 2002.